Trial Profile
An Open-Label, Randomized Clinical Study to Evaluate the Efficacy, Safety and Genetic Polymorphism of Hypoca(Barnidipine)and Adalat OROS(Nifedipine) in Mild to Moderate Hypertensive Patients
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Barnidipine (Primary) ; Nifedipine (Primary)
- Indications Hypertension
- Focus Pharmacogenomic; Therapeutic Use
- 22 Aug 2008 New trial record.